By analyzing 89 plasma specimens from GC patients, 82 control plasma specimens, and 56 pairs of GC and adjacent tissues, cfDNAs including DOCK10, CABIN1, and KCNQ5, are identified to detect and discriminate GC, providing strong data support for noninvasive blood screening of GC.74 This evidence concerns the gene CABIN1 and gastric cancer.